BRKR Bruker Corporation
$60.74▲ +4.31%
Healthcare
Other
After hours
$60.74▲ +0.00%
Oct 27, 5:23 PM ET
Volume 2.29M
Avg Volume (10D) 2.13M
Key Metrics & Fundamentals
Market Cap
$9.25B
P/E Ratio
–
Div Yield
0.34%
52W Range
32.37 - 66.98
% vs 50 MA
3.32%
% vs 200 MA
21.29%
RSI-14
56.0
MACD Histogram
+0.2100
Beta (1Y vs SPY)
1.41
Free Cash Flow
-$106.20M
Gross Rev
$838.50M
Gross Profit
$416.00M
EBITDA
$182.60M
COGS
$422.50M
Operating Exp
$333.20M
Operating Income
$82.80M
EBIT
$82.80M
Pretax Income
-$40.70M
Net Income
-$52.00M
EPS (Diluted)
-0.41
Price & Volume History
Loading chart…
Recent News
1 healthcare stock for long-term investors and 2 we ignore
StockStory · Oct 26, 2026 2:30 PM ET
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Business Wire · Oct 20, 2026 4:01 PM ET
JPMorgan Downgrades Bruker to Neutral From Overweight, Price Target is $60
MT Newswires · Oct 14, 2026 6:02 AM ET
3 Reasons BRKR is Risky and 1 Stock to Buy Instead
StockStory · Oct 12, 2026 4:47 PM ET
Why Is Bruker (BRKR) Getting Attention For Its Human Plasma Proteome Atlas?
Simply Wall St. · Oct 9, 2026 4:15 AM ET
Bruker (BRKR), Why Is Its Latest Update Drawing Fresh Attention?
Simply Wall St. · Oct 8, 2026 4:11 PM ET
Bruker Gains 66.3% in a Year: What's Driving the Rally?
Zacks · Oct 8, 2026 9:39 AM ET
3 Cash-Producing Stocks We Steer Clear Of
StockStory · Oct 7, 2026 5:04 AM ET
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
Business Wire · Oct 6, 2026 7:00 AM ET
Are Options Traders Betting on a Big Move in Bruker Stock?
Zacks · Oct 5, 2026 11:07 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BRKR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.